FIDA BACHA to United States
This is a "connection" page, showing publications FIDA BACHA has written about United States.
Connection Strength
0.184
-
FDA approval of GLP-1 receptor agonist (liraglutide) for use in children. Lancet Child Adolesc Health. 2019 09; 3(9):595-597.
Score: 0.052
-
Type 2 diabetes in youth: are there racial differences in ?-cell responsiveness relative to insulin sensitivity? Pediatr Diabetes. 2012 May; 13(3):259-65.
Score: 0.030
-
The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange. Diabetes Care. 2020 04; 43(4):806-812.
Score: 0.027
-
Does adiponectin explain the lower insulin sensitivity and hyperinsulinemia of African-American children? Pediatr Diabetes. 2005 Jun; 6(2):100-2.
Score: 0.020
-
Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry. J Clin Endocrinol Metab. 2020 05 01; 105(5).
Score: 0.014
-
Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical?Trial. Am J Kidney Dis. 2018 01; 71(1):65-74.
Score: 0.012
-
A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry. Pediatr Diabetes. 2017 05; 18(3):222-229.
Score: 0.010
-
Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States. J Pediatr. 2015 Sep; 167(3):627-32.e1-4.
Score: 0.010
-
Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care. 2006 Jan; 29(1):51-6.
Score: 0.005
-
Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth. Diabetes Care. 2005 Jan; 28(1):115-9.
Score: 0.005